Vapers Digest 6th July
Monday’s News at a glance:
Majority of UK smokers wrongly believe vaping is as harmful as cigarettes, experts find ~ American Lung Association Finds It “Appalling” that Nicotine Pouch Maker is Allowed to Tell the Truth ~ New Zealand’s Accelerated Decline in Smoking after Embracing E-Cigarettes ~ FDA recognises nicotine pouches life-saving potential as Europe heads in the opposite direction ~ FDA Says ZYN Can Be Marketed as Lower-Risk Than Cigarettes ~ PMI defends AI consultation tool as scrutiny grows over EU tobacco rules review ~ Tobacco Harm Reduction IS Harm Reduction ~ Responses to ZYN MRTP Announcement ~ Untethered | FDA’s Flavor Policy Defies Reality | RegWatch ~ Parliament | Tobacco Bill proceeds to next stage: Dr Kgosi Letlape ~ The Nicotine-Free Generation: Prohibition That Doesn’t Work? | Inside Sources Editorial Board ~ The real costs of prohibition | #GFN26 Panel ~ How should we think about nicotine addiction? | THR Unfiltered
Majority of UK smokers wrongly believe vaping is as harmful as cigarettes, experts find
Ian Sample, The Guardian
More than half of adult smokers in the UK wrongly believe that vaping is as harmful or more harmful than cigarettes, making them less likely to switch to vapes and quit the deadly habit, research has found.
Evidence from scientific studies shows that, while vaping is not risk-free, it is far less harmful than smoking tobacco, which produces thousands of chemicals, including toxic metals, poisonous gases and substances that cause cancer.
American Lung Association Finds It “Appalling”
that Nicotine Pouch Maker is Allowed to Tell the Truth
Michael Siegel, The Rest of the Story
It used to be that we castigated the tobacco companies for lying to or misleading the public. Now, apparently, we think that it’s appalling that a tobacco company be allowed to tell the truth.
Years ago, I testified in the Engle case, a class action suit brought by Florida smokers against Big Tobacco that resulted in a $145 billion punitive damage verdict against the companies. The basis of the lawsuit was that for years, the tobacco companies lied about the health effects of their products and were liable for damages based on their fraudulent behavior. And in a more recent lawsuit, the tobacco companies were forced to put corrective statements on cigarette packs in order to atone for deceptive statements they had made in the past. Clearly, a major problem for which we held tobacco companies responsible was lying to the public about the health effects of their products.
New Zealand’s Accelerated Decline in Smoking after Embracing E-Cigarettes
Arielle Selya PhD, Selya Behavioral Science Substack
Beaglehole et al.’s article presents a straightforward analysis of the adult smoking rate in New Zealand. Critical context is that in 2019, New Zealand’s Ministry of Health officially endorsed e-cigarettes as a tool for smoking cessation and harm reduction. Beaglehole et al. performed a joinpoint analysis, which (for the non-statisticians out there) takes a trend over time and does some math to fit the curve to a series of straight lines, and tells you where the slope of the lines changed.
FDA recognises nicotine pouches life-saving potential
as Europe heads in the opposite direction
Smoke Free Sweden
The world’s most influential health regulator has recognised that nicotine pouches can dramatically reduce smokers’ risk of deadly disease – just as the European Union is considering new restrictions that could make these products less accessible.
FDA Says ZYN Can Be Marketed as Lower-Risk Than Cigarettes
Michael Graham, DC Journal
The Food and Drug Administration on Tuesday authorized ZYN to be marketed as a lower-risk alternative to cigarettes, the first time a nicotine pouch has cleared that high regulatory bar. It’s a big win for advocates of “harm reduction” public health policy and a setback to anti-nicotine activist groups lobbying for prohibition and products bans.
PMI defends AI consultation tool as scrutiny grows over EU tobacco rules review
Colin Stevens, EU Reporter
The controversy comes as Brussels prepares a major review of the Tobacco Products Directive (TPD) and the Tobacco Advertising Directive, two central pillars of the EU’s tobacco-control framework.
The European Commission launched a call for evidence on 18 May 2026, followed by a public consultation on 22 May, seeking views from citizens, public authorities, businesses, academics, researchers, civil society organisations and other stakeholders.
Two From Skip Murray, Skip’s Corner – Let’s Talk!
Tobacco Harm Reduction IS Harm Reduction
World Vape Day and World No Tobacco Day fall one day apart. That timing makes the contrast hard to ignore. As I watched posts on social media over those two days, the contrast was even deeper than in years past.In many areas of public health, harm reduction is treated as practical, compassionate, and evidence-informed. Public health organizations recognize that people do not always stop risky behaviors immediately, completely, or as professionals might prefer. They promote safer choices, person-first language, stigma reduction, and the meaningful inclusion of people with lived experience.
Responses to ZYN MRTP Announcement
Before we dive into today’s post about responses to the announcement of the MRTP marketing authorization of 20 ZYN products, I thought it would be interesting to look at how we got here.
Brief background behind the history of the FDA
I had always believed that the FD&C Act was what gave birth to the FDA. I was wrong! It delights me to learn something new, and I want to share my joy in case it helps any of my readers learn something new as well.
Brent Stafford, RegulatorWatch / RegWatch
The FDA says its policy restricting flavors in nicotine vaping products is for the protection of public health. But is it? With a singular focus on youth, the agency ignores tens of millions of adult Americans who still smoke tobacco or have already switched to safer nicotine—while protecting the cigarette industry and pouring fuel on an exploding, billion-dollar illicit vape market.
In this episode of RegWatch, tobacco control expert Clive Bates dismantles FDA’s flavor guidance, the absurd comparative-efficacy standard, and the growing global push to eradicate nicotine rather than reduce smoking.
Parliament | Tobacco Bill proceeds to next stage: Dr Kgosi Letlape
SABC News
After years of delays, debate and thousands of public submissions, the Portfolio Committee on Health today voted in favour of the desirability of the Tobacco Products and Electronic Delivery Systems Control Bill.
The Nicotine-Free Generation: Prohibition That Doesn’t Work?
Panel with Dr. Michael Siegel, Dr. Jeff Willett, Deputy Chief Wayne Harris, InsideSources
An Inside Sources editorial board on Massachusetts’ nicotine-free generation laws — age-based policies now in 25 communities that ban nicotine sales to anyone born after a certain date.
A Tufts physician, a Progressive Policy Institute researcher, and a retired police chief explain why these laws are prohibition by another name: abandoning 30 million adult smokers, doing nothing about youth use that’s already at historic lows, and feeding a black market that’s far more dangerous than the legal products they’re replacing.

Two From Global Forum on Nicotine
The real costs of prohibition | #GFN26 Panel
At the Global Forum on Nicotine (GFN26), leading experts examine one of the most controversial questions in public health: What are the real costs of vaping prohibition?
This panel explores the unintended consequences of restrictive nicotine policies, including black markets, reduced access to safer nicotine alternatives, impacts on smoking cessation, and the broader implications for public health. Drawing on scientific evidence and international experience, the speakers discuss whether prohibition achieves its intended goals—or creates new problems.
How should we think about nicotine addiction? | THR Unfiltered
Can we rethink nicotine addiction? Is the word “addiction” helping—or hurting—the conversation? In this episode of THR Unfiltered, recorded during the Global Forum on Nicotine 2026 #GFN26 we speak with behavioral scientist Dr. Arielle Selya about the science behind nicotine dependence, addiction, and tobacco harm reduction. The discussion explores why researchers often prefer the term “dependence” over “addiction,” how these concepts differ in scientific and clinical contexts, and why language matters when discussing people who use nicotine.
A look back at how things have moved on or otherwise…
Petition to Halt EU-Wide Vaping Tax
Diane Caruana, Vaping Post
The New Nicotine Alliance (NNA), a UK registered charitable incorporated organisation “concerned with improving public health, through a greater understanding of “new” (risk-reduced) nicotine products and their uses” is supporting an initiative by French organization SOVAPE.
Andy Morrison at the #GFN2018
New Nicotine Alliance
What’s important now for me as a consumer is what you guys do when you leave here, as groups or as individuals. A lot of people are rightly looking to the UK as being a good place for harm reduction, particularly in this field but again, being a Scotsman we don’t particularly like the UK and we’ve got a little saying that says “we’re daein well but we’re no daein great”. I’ll translate that into English for you: “We’re doing very well but we’re not doing brilliantly”.
Visit Nicotine Science & Policy for more News from around the World








